[
  {
    "pageContent": "{\"position\":1,\"title\":\"Efficacy of statins for primary prevention in people at low ...\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216447/\",\"redirect_link\":\"https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216447/&ved=2ahUKEwiTorWa29yDAxWbv4kEHcW2DW0QFnoECBcQAQ\",\"displayed_link\":\"https://www.ncbi.nlm.nih.gov › articles › PMC3216447\",\"favicon\":\"https://serpapi.com/searches/65a3bd0911c881f6a7dd3144/images/24573ab0ef48738c1074e6d4b673f2ed83ca3e53d7914e2bf498f0e365b10f9e.png\",\"author\":\"by M Tonelli\",\"cited_by\":\"Cited by 213\",\"extracted_cited_by\":213,\"date\":\"2011\",\"snippet\":\"Statins were found to be efficacious in preventing death and cardiovascular morbidity in people at low cardiovascular risk. Reductions in relative risk were ...\",\"snippet_highlighted_words\":[\"Statins\",\"efficacious\",\"preventing\",\"cardiovascular\",\"cardiovascular\"],\"sitelinks\":{\"inline\":[{\"title\":\"Efficacy Of Statins For...\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216447/#:~:text=Efficacy%20of%20statins%20for%20primary%20prevention%20in%20people%20at%20low%20cardiovascular%20risk%3A%20a%20meta%2Danalysis,-Marcello%20Tonelli%2C%20MD%20SM\"},{\"title\":\"Table 1\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216447/#:~:text=Table%201%3A\"},{\"title\":\"Table 3\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216447/#:~:text=Table%203%3A\"}]},\"source\":\"nih.gov\"}",
    "metadata": {
      "source": "SerpAPI",
      "responseType": "organic_results"
    }
  },
  {
    "pageContent": "{\"position\":2,\"title\":\"Rosuvastatin: A Review of the Pharmacology and Clinical ...\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303484/\",\"redirect_link\":\"https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303484/&ved=2ahUKEwiTorWa29yDAxWbv4kEHcW2DW0QFnoECBAQAQ\",\"displayed_link\":\"https://www.ncbi.nlm.nih.gov › articles › PMC3303484\",\"favicon\":\"https://serpapi.com/searches/65a3bd0911c881f6a7dd3144/images/24573ab0ef48738c1074e6d4b673f2edd970340ac8bf3e9703dbc01e5d4b7e9a.png\",\"author\":\"by A Luvai\",\"cited_by\":\"Cited by 189\",\"extracted_cited_by\":189,\"date\":\"2012\",\"snippet\":\"The 4S study was the first study conclusively linking a statin with improved outcomes in patients with coronary heart disease. It established ...\",\"snippet_highlighted_words\":[\"improved outcomes\"],\"source\":\"nih.gov\"}",
    "metadata": {
      "source": "SerpAPI",
      "responseType": "organic_results"
    }
  },
  {
    "pageContent": "{\"position\":3,\"title\":\"Efficacy and safety of the intensive dose of rosuvastatin 40 ...\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143813/\",\"redirect_link\":\"https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143813/&ved=2ahUKEwiTorWa29yDAxWbv4kEHcW2DW0QFnoECBEQAQ\",\"displayed_link\":\"https://www.ncbi.nlm.nih.gov › articles › PMC5143813\",\"favicon\":\"https://serpapi.com/searches/65a3bd0911c881f6a7dd3144/images/24573ab0ef48738c1074e6d4b673f2edbe2f81983f9029e138e7234f888abbd6.png\",\"author\":\"by CP Shah\",\"cited_by\":\"Cited by 15\",\"extracted_cited_by\":15,\"date\":\"2016\",\"snippet\":\"The study showed that rosuvastatin 20 mg is as effective as atorvastatin 80 mg in intensive statin treatment. There is dearth of data on effect ...\",\"snippet_highlighted_words\":[\"rosuvastatin 20 mg is as effective as atorvastatin 80 mg\"],\"source\":\"nih.gov\"}",
    "metadata": {
      "source": "SerpAPI",
      "responseType": "organic_results"
    }
  },
  {
    "pageContent": "{\"position\":4,\"title\":\"Rosuvastatin for primary prevention in patients with ...\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3013199/\",\"redirect_link\":\"https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3013199/&ved=2ahUKEwiTorWa29yDAxWbv4kEHcW2DW0QFnoECBQQAQ\",\"displayed_link\":\"https://www.ncbi.nlm.nih.gov › articles › PMC3013199\",\"favicon\":\"https://serpapi.com/searches/65a3bd0911c881f6a7dd3144/images/24573ab0ef48738c1074e6d4b673f2ed80d12150784d40ece2f2e7ad68380b1f.png\",\"author\":\"by W Koenig\",\"cited_by\":\"Cited by 64\",\"extracted_cited_by\":64,\"date\":\"2011\",\"snippet\":\"On the basis of the JUPITER trial, European health authorities recently approved the use of rosuvastatin to reduce first major cardiovascular ...\",\"snippet_highlighted_words\":[\"rosuvastatin\",\"reduce\",\"cardiovascular\"],\"sitelinks\":{\"inline\":[{\"title\":\"Methods\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3013199/#:~:text=Methods,-JUPITER%20was%20a%20double%2D\"},{\"title\":\"Results\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3013199/#:~:text=Results,-JUPITER%20enrolled%2017%20802%20men\"},{\"title\":\"Table 3\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3013199/#:~:text=Table%203,-Major%20cardiovascular%20events%20and%20all\"}]},\"source\":\"nih.gov\"}",
    "metadata": {
      "source": "SerpAPI",
      "responseType": "organic_results"
    }
  },
  {
    "pageContent": "{\"position\":5,\"title\":\"Comparative efficacy between atorvastatin and ...\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905000/\",\"redirect_link\":\"https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905000/&ved=2ahUKEwiTorWa29yDAxWbv4kEHcW2DW0QFnoECBYQAQ\",\"displayed_link\":\"https://www.ncbi.nlm.nih.gov › articles › PMC6905000\",\"favicon\":\"https://serpapi.com/searches/65a3bd0911c881f6a7dd3144/images/24573ab0ef48738c1074e6d4b673f2ed240eed28476886dfb32a7917083c5907.png\",\"author\":\"by S Perez-Calahorra\",\"cited_by\":\"Cited by 31\",\"extracted_cited_by\":31,\"date\":\"2019\",\"snippet\":\"Atorvastatin provided greater protection against death or major cardiovascular events than pravastatin did. However, they used different doses, ...\",\"snippet_highlighted_words\":[\"provided greater protection against death or major cardiovascular events\"],\"source\":\"nih.gov\"}",
    "metadata": {
      "source": "SerpAPI",
      "responseType": "organic_results"
    }
  },
  {
    "pageContent": "{\"position\":6,\"title\":\"Statins for the primary prevention of cardiovascular disease\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481400/\",\"redirect_link\":\"https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481400/&ved=2ahUKEwiTorWa29yDAxWbv4kEHcW2DW0QFnoECA8QAQ\",\"displayed_link\":\"https://www.ncbi.nlm.nih.gov › articles › PMC6481400\",\"favicon\":\"https://serpapi.com/searches/65a3bd0911c881f6a7dd3144/images/24573ab0ef48738c1074e6d4b673f2edd101e8f3cfe0d03331df69cd8aad24f6.png\",\"author\":\"by F Taylor\",\"cited_by\":\"Cited by 2593\",\"extracted_cited_by\":2593,\"date\":\"2013\",\"snippet\":\"A 2012 CTT Collaboration report further demonstrated a consistent 20% relative risk reduction in major vascular events with statins per 1mmol/L reduction in LDL ...\",\"snippet_highlighted_words\":[\"consistent 20% relative risk reduction\"],\"source\":\"nih.gov\"}",
    "metadata": {
      "source": "SerpAPI",
      "responseType": "organic_results"
    }
  },
  {
    "pageContent": "{\"position\":7,\"title\":\"Real-World Clinical Experience of Rosuvastatin as a Lipid ...\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748627/\",\"redirect_link\":\"https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748627/&ved=2ahUKEwiTorWa29yDAxWbv4kEHcW2DW0QFnoECCwQAQ\",\"displayed_link\":\"https://www.ncbi.nlm.nih.gov › articles › PMC9748627\",\"favicon\":\"https://serpapi.com/searches/65a3bd0911c881f6a7dd3144/images/24573ab0ef48738c1074e6d4b673f2ed86e76169c58ebf1678c3cffae1157105.png\",\"author\":\"by A Mehta\",\"cited_by\":\"Cited by 1\",\"extracted_cited_by\":1,\"date\":\"2022\",\"snippet\":\"Various clinical studies have reported better efficacy of rosuvastatin in reducing LDL cholesterol, increasing HDL cholesterol, and being useful ...\",\"snippet_highlighted_words\":[\"better efficacy\"],\"source\":\"nih.gov\"}",
    "metadata": {
      "source": "SerpAPI",
      "responseType": "organic_results"
    }
  },
  {
    "pageContent": "{\"position\":8,\"title\":\"Dose study of rosuvastatin calcium in the treatment ...\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250966/\",\"redirect_link\":\"https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250966/&ved=2ahUKEwiTorWa29yDAxWbv4kEHcW2DW0QFnoECCQQAQ\",\"displayed_link\":\"https://www.ncbi.nlm.nih.gov › articles › PMC10250966\",\"favicon\":\"https://serpapi.com/searches/65a3bd0911c881f6a7dd3144/images/24573ab0ef48738c1074e6d4b673f2edb23d75c5aaff56ee7f70f6b34af04808.png\",\"author\":\"by J Zhang\",\"date\":\"2023\",\"snippet\":\"Objective: To study the clinical efficacy of different doses of rosuvastatin to treat elderly patients with senile coronary heart disease ...\",\"snippet_highlighted_words\":[\"efficacy\",\"rosuvastatin\",\"heart disease\"],\"source\":\"nih.gov\"}",
    "metadata": {
      "source": "SerpAPI",
      "responseType": "organic_results"
    }
  },
  {
    "pageContent": "{\"position\":9,\"title\":\"Statins for the Primary Prevention of Coronary Heart Disease\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374814/\",\"redirect_link\":\"https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374814/&ved=2ahUKEwiTorWa29yDAxWbv4kEHcW2DW0QFnoECCsQAQ\",\"displayed_link\":\"https://www.ncbi.nlm.nih.gov › articles › PMC6374814\",\"favicon\":\"https://serpapi.com/searches/65a3bd0911c881f6a7dd3144/images/24573ab0ef48738c1074e6d4b673f2ed4c0f7dce0c9bbd5c77b050aeb1ec32a8.png\",\"author\":\"by M Li\",\"cited_by\":\"Cited by 35\",\"extracted_cited_by\":35,\"date\":\"2019\",\"snippet\":\"Compared with the control group, the statin group showed that statins can effectively reduce the risk of cardiovascular events (RR=0.77, 95% CI: ...\",\"snippet_highlighted_words\":[\"statins can effectively reduce the risk of cardiovascular events\"],\"sitelinks\":{\"inline\":[{\"title\":\"1. Introduction\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374814/#:~:text=1.%20Introduction,-Cardiovascular%20diseases%20%28CVDs%29\"},{\"title\":\"2. Methods\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374814/#:~:text=2.%20Methods,-This%20study%20was%20performed%20in\"},{\"title\":\"3. Results\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374814/#:~:text=3.%20Results,-3.1.%20Description%20of%20Included\"}]},\"source\":\"nih.gov\"}",
    "metadata": {
      "source": "SerpAPI",
      "responseType": "organic_results"
    }
  },
  {
    "pageContent": "{\"position\":10,\"title\":\"The Efficacy of Rosuvastatin, Amlodipine, and Aspirin in ...\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588327/\",\"redirect_link\":\"https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588327/&ved=2ahUKEwiTorWa29yDAxWbv4kEHcW2DW0QFnoECCUQAQ\",\"displayed_link\":\"https://www.ncbi.nlm.nih.gov › articles › PMC9588327\",\"favicon\":\"https://serpapi.com/searches/65a3bd0911c881f6a7dd3144/images/24573ab0ef48738c1074e6d4b673f2ed7656b74e2a31dd3b611828a664fb41bb.png\",\"author\":\"by J Fu\",\"cited_by\":\"Cited by 2\",\"extracted_cited_by\":2,\"date\":\"2022\",\"snippet\":\"Conclusion. The clinical efficacy of rosuvastatin, amlodipine, and aspirin markedly reduces the blood pressure indices, blood lipid indices, ...\",\"snippet_highlighted_words\":[\"markedly reduces the blood pressure\"],\"source\":\"nih.gov\"}",
    "metadata": {
      "source": "SerpAPI",
      "responseType": "organic_results"
    }
  }
]